Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Global Ventricular Arrhythmia API Manufacturers, Marketed and Phase III Drugs Landscape Report 2017-2018 - Research and Markets

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/17/2017 | 07:52pm CEST

Research and Markets has announced the addition of the "Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Ventricular Arrhythmia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Ventricular Arrhythmia Report is to understand the market and pipeline status of the drugs around the Ventricular Arrhythmia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Ventricular Arrhythmia Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Ventricular Arrhythmia.

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Ventricular Arrhythmia

7. Phase III Drugs for Ventricular Arrhythmia

8. Discontinued Drugs for Ventricular Arrhythmia

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/cs9gkq/ventricular


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
04:02p NOUVEAU MONDE GRAPHITE : Announces closing of the second tranche $9,246,052 financing
04:01p TENNESSEANS, HELP FIGHT THE OPIOID EPIDEMIC : Participate in National Drug Take-Back Day Oct. 28
03:58p SUBARU : Governor says change-resistant Indiana should think globally
03:56p Board of directors meeting of First Equity Modaraba
03:55p SECURITY INVESTMENT BANK : Board of directors meeting of Security Investment Bank Limited
03:55p WAL MART STORES : Thank you to the heroic stranger who helped me out
03:53p AL SHAHEER : Board of directors meeting of Al Shaheer Corporation Limited
03:53p FAUJI FERTILIZER : Financial results of Fauji Fertilizer Company Limited for Quarter ended September 30, 2017
03:52p Board of directors meeting of Zephyr Textiles Limited
03:52p Board of directors meeting of Arpak International Investment Limited
Latest news "Companies"
Advertisement